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Early detection of persons with first signs of emerging psychosis is regarded as a promising
strategy to reduce the burden of the disease. In recent years, there has been increasing
interest in early detection of psychosis and bipolar disorders, with a clear need for sufficient
sample sizes in prospective research.The underlying brain network disturbances in individ-
uals at risk or with a prodrome are complex and yet not well known. This paper provides
the rationale and design of a prospective longitudinal study focused on at-risk states of
psychosis and bipolar disorder.The study is carried out within the context of the Zurich Pro-
gram for Sustainable Development of Mental Health services (Zürcher Impulsprogramm
zur Nachhaltigen Entwicklung der Psychiatrie). Persons at risk for psychosis or bipolar
disorder between 13 and 35 years of age are examined by using a multi-level-approach
(psychopathology, neuropsychology, genetics, electrophysiology, sociophysiology, mag-
netic resonance imaging, near-infrared spectroscopy).The included adolescents and young
adults have four follow-ups at 6, 12, 24, and 36 months. This approach provides data for a
better understanding of the relevant mechanisms involved in the onset of psychosis and
bipolar disorder, which can serve as targets for future interventions. But for daily clinical
practice a practicable “early recognition” approach is required.The results of this study will
be useful to identify the strongest predictors and to delineate a prediction model.
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INTRODUCTION
Early detection and prevention is considered an essential strategy
to reduce years lived with disability (YLD) and reduce the stigma
attached to mental disorders (1). However, in some people the
initial symptoms are not properly recognized (2, 3). Lack or delay
of treatment can lead to an unfavorable or chronic course of the
illness (4, 5). Research on the psychosis risk syndrome, which aims
to reduce transition rates to psychosis, presents a challenge to cur-
rent ascertainment and intervention methods (6). Some at-risk
individuals do not convert to psychosis, but have outcomes that
fall within the spectrum of psychotic disorders. Therefore, it is
necessary to improve knowledge about prediction. Currently, new
methodological approaches such as multivariate modeling and
machine learning methods are discussed in regard to the prospects
and caveats (7–10). At the same time, the field is moving toward
extending efforts to study the bipolar disorder risk syndrome (11).
The first phase of research into early recognition of psychosis
tended to favor specific assessment tools, definition of high-risk
(HR) criteria and outcomes as well as the application of these
methods (11–14). Even if the duration of untreated psychosis
(DUP) has been shortened in the last years, an average of 1 year
DUP in highly developed health care systems remains (15). But
once basic symptoms and “ultra-high risk” (UHR)-symptoms
are detectable, associated pathophysiology may have already pro-
gressed (16). Assuming that the brain is a complex structure in
which anatomical and functional connectivity occurs at many lev-
els (17), that plasticity occurs during all stages of development and
that environmental factors can also have important effects on brain
functions, psychiatry must take various levels of evidence into
account (18). To detect this underlying pathophysiology, putative
biomarkers, and intermediary phenotypes need to be developed
and tested in a sufficiently large cohort with members truly at
risk for psychosis (14). The diagnostic process of bipolar disor-
der is made more difficult, especially in young people, by complex
diagnostic conditions from which bipolar disorder must be distin-
guished and also from the occurrence of adverse life circumstances,
all of which do not facilitate the diagnostic process (19). A com-
bination of clinical risk factors with precursors and family-risk
could improve early identification of bipolar disorder (20). Even
though there is evidence suggesting that the characterization of
early phases in the development of the bipolar disorder is viable
further evaluation in larger, prospective studies is needed (21–24).
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There is evidence for a substantial overlap in genetic susceptibil-
ity to bipolar disorder and schizophrenia but also for the existence
of non-shared genetic risk factors (25–27). However, attenuated
positive symptoms occur in both the schizophrenic and the bipo-
lar prodromal phase (22, 28, 29). Potential analogy between the
genetic and phenotypic overlap between both phases raises the
question about the nature of the at-risk phase of different mental
disorders.
Previous research into the prodromal phase of first-episode
psychosis has brought knowledge regarding the development of
psychosis (30). But until now it is unclear to what extent the
findings from research into the prodromal phase of first-episode
psychosis reflect psychiatric distress in general and to what extent
they are specifically associated with the development of a full-
blown psychotic disorder (30). It may be that a more general
strategy for early intervention in a range of mental disorders could
be a useful approach. Many disorders could develop from initial
non-specific symptoms and syndromes, i.e., from a background
of specific and non-specific risk factors (31). Understanding the
interplay of developmental factors and pathophysiological changes
will help to study the moderating risk and resilience factors.
Main objective of the ZInEP “early recognition” study is to
develop a risk model to estimate conversion risk and to specify how
environmental and pathophysiological factors affect functioning.
We hypothesize that our defined at-risk groups for psychosis and
bipolar disorder could be distinguished based on the neurocog-
nitive and neurobiological measures. In this paper, we present an
overview of the study methodology and the characteristics of the
sample recruited so far.
MATERIALS AND METHODS
STUDY DESIGN
The Zurich Early Recognition Program [part of The Zurich Pro-
gram for Sustainable Development of Mental Health services
(Zürcher Impulsprogramm zur nachhaltigen Entwicklung der
Psychiatrie; www.zinep.ch)] is based in a catchment area in the
Canton Zurich, Switzerland with approximately 1,300,000 inhab-
itants. Our study has a longitudinal multi-level design with a
baseline assessment and four follow-up examinations at 6, 12, 24,
and 36 months or if transition to full-blown psychotic or affective
disorder occurs.
REFERRAL AND RECRUITMENT
All persons in the indicated age range (subjects between 13 and
35 years of age) presenting to any of our four study centers, situ-
ated in urban area, and embedded into established early recog-
nition units, were screened for the presence of the inclusion
criteria. Psychiatrists, child and adolescent psychiatrists, psychol-
ogists, general practitioners, outreach clinics, counseling services,
teachers, and affected persons or their worried family members
could refer to the early recognition units (hospital based units
employing standardized criteria to identify persons at risk for psy-
chosis or bipolar disorder and offering appropriate counseling).
We provided information about the study through local work-
shops, articles in professional journals, flyers, and a study-website.
If at least one inclusion criterion was fulfilled and the participants
gave written informed consent, the baseline examination including
clinical (including blood analysis), psychopathological, neurocog-
nitive, neurophysiological, genetic, sociophysiological, and mag-
netic resonance (MR) measures were performed. We also recruited
normal control subjects from the community by way of advertise-
ments. They were healthy volunteers, aged 13–35 years, without
any personal history of psychiatric illness including schizophrenia,
bipolar, or other psychotic disorders.
PARTICIPANTS
For inclusion, participants had to fulfill at least one of the follow-
ing three criteria (listed in Table 1): (i) HR status for psychosis
assessed by the adult (14) or children-youth (32, 33) version of the
Schizophrenia Proneness Interview, with at least one cognitive–
perceptive basic symptom or at least two cognitive disturbances; or
(ii) ultra-HR status (UHR) for psychosis as rated by the Structured
Interview for Prodromal Syndromes (SIPS) (12, 34) with at least
one attenuated psychotic symptom, or at least one brief limited
intermittent psychotic symptom, or state-trait criteria [reduction
in global assessment of functioning (GAF) of >30% in the past
year plus either schizotypal personality disorder or a first degree
relative with psychosis]; or (iii) risk of bipolar disorder (at-risk bp),
defined by a score ≥14 in the hypomania checklist, a self-report
measure of life-time hypomanic symptoms (35).
Exclusion criteria for study participation were diagnosed schiz-
ophrenic, substance-induced or organic psychosis, other sympto-
matic organic mental disorders, manifest bipolar disorder, current
substance, or alcohol dependence, age below 13 or above 35 years,
incapacity to consent, e.g., due to an acute and severe psychopatho-
logical state or low intellectual abilities with IQ<80. Axis-I comor-
bidity was assessed by the Mini-International Neuropsychiatric
Interview based on DSM-IV criteria (36). The presence of psy-
chotic symptoms for more than 1 week was assessed. Transition
to psychosis or bipolar disorder was defined according to ICD-10
criteria.
INFORMED CONSENT
Adult and young persons were informed about the study by a
research-psychologist or research-psychiatrist by means of a com-
prehensive information letter. When all the information on the
trial was understood, the consent form was signed (up to age 18 by
both the adolescent and their parents) and the person was invited
for the first screening. Participants could always withdraw from
Table 1 | Risk groups.
High-risk (HR) for psychosis
at least one cognitive–perceptive basic symptom or
at least two cognitive disturbances
Ultra-high-risk (UHR) for psychosis
at least one attenuated psychotic symptom or
at least one brief limited intermittent psychotic symptom or
state-trait criteria (reduction in global assessment of functioning
of >30% in the past year plus either schizotypal personality disorder
or a first degree relative with psychosis)
Risk of bipolar disorder (at-risk bp)
defined by a score ≥14 in the Hypomania Checklist
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participating in the study. The study was approved by the local
ethics committee and conducted in accordance with the guidelines
of the Helsinki Declaration.
ASSESSMENTS
A multi-level assessment of psychopathology,neurocognitive,neu-
rophysiological, genetic, structural, and functional brain abnor-
malities is carried out.
Information on psychopathology was gathered with the Schiz-
ophrenia Prediction Instrument-adult (14) and -child and youth
Version (SPI-CY, SPI-A) (32, 33), the SIPS (12, 34), the Pos-
itive and Negative Symptom Scale (PANSS) (37), Hypomania
Checklist (HCL-32) (35), Calgary Depression Scale (38), Hamil-
ton Depression Scale (HAMD) (39), and Beck Anxiety Inventory
(BAI) (40).
Data about the socio-demographic background, physical
health, obstetric and family history, premorbid adjustment, func-
tioning and disability by psychiatric symptoms, daily hassles stress,
and quality of life were collected via: Obstetric Complications
Scale (OCS) (41), Clinical Global Impression Rating Scales (CGI)
(42), GAF (43), Hopkins Symptom Checklist (SCL-90-R) (44),
Camberwell Assessment of Need (CAN) (45), the General Self-
Efficacy-Scale (GSE) (46), Daily Hassles and Stress Scale (DHSS)
(47), Manchester Short Assessment of Quality of Life (MANSA)
(48). All investigators were either psychologists or psychiatrists
who received extensive training.
NEUROCOGNITIVE ASSESSMENTS
A set of well-established neuropsychological tests was adminis-
tered in accordance with the MATRIC Consensus Cognitive Bat-
tery (49–51). Verbal IQ was estimated with a word recognition test
(MWT-B) for adults (52) and a test of receptive vocabulary for
adolescents (PPVT) (53). Abstract reasoning abilities were esti-
mated using a non-verbal task (scale 3 of LPS) (54). Measures of
attention were assessed by Continuous Performance Test (CPT-
OX) (55), a test of selective attention (FAIR) (56), the Stroop Test
(57), and the divided attention subtest of a computer-administered
test series (TAP) (58). The Trail Making Test Parts A and B (59)
were used to assess psychomotor speed, attention, and cognitive
flexibility.
Measures of verbal and figural learning and memory were col-
lected from a German Auditory Verbal Learning Test (60, 61) and
from the Rey Visual Design Learning Test (57).
Measures of executive function were provided by a test of
verbal (RWT) and figural (five-point test) fluency (62, 63), work-
ing memory by subtests of the Wechsler Adult Intelligence Scale
(WIE) (64),a computer-administered Wisconsin Card Sorting Test
(CKV) (65), and Tower of Hanoi (ToH) (66).
MOLECULAR GENETIC STUDIES
Genetic and epigenetic studies will be carried out in the Neuro-
biochemistry Laboratory of the University Hospital of Child and
Adolescent Psychiatry (E. Grünblatt, S. Walitza) together with the
Institute of Medical Genetics, University of Zurich (A. Rauch).
Peripheral blood samples were collected from at-risk individu-
als for DNA and RNA (PAXgene Blood RNA Tubes) analysis.
For gene expression profiling, RNA was reverse-transcribed into
cDNA using the iScript cDNA synthesis kit. Using quantitative
real-time RT-PCR, the profile of transcript for various genes was
investigated. DNA is available from 218 participants, of whom
2/3 are adolescents while the other 1/3 are young adults. Var-
ious candidate gene variations (SNPs and polymorphism) and
gene expression analyses have been performed up to now (e.g.,
d-amino acid oxidase activator, dopamine transporter, neuroreg-
ulin). Genome wide CNV analysis in at-risk persons for psychosis
and bipolar disorders is still on-going.
MAGNETIC RESONANCE IMAGING
Images were collected on a Philips Achieva 3 Tesla magnetic
resonance imaging (MRI) scanner equipped with an 8-channel
standard head coil. The MR-images of all participants were rated
by the Department of Neuroradiology at the University of Zurich
for exclusion of a visible organic brain disease.
The intended analyses of the MRI data include voxel based mor-
phometry (VBM) and diffusion tensor imaging (DTI) to detect
alterations of the cortical structure and the white matter in indi-
viduals at-risk. Intrinsic functional connectivity is examined based
on resting state functional MRI data (6-min runs). In addition, a
reward task [Monetary Incentive Delay Task (67)] was performed
to identify possible dysregulations of the dopaminergic system
by investigating the neural responses to reward expectation and
reward outcomes.
CLINICAL NEUROPHYSIOLOGY
EEG data are recorded with a BrainAmp 32 channel-amplifier.
Brain Vision Recorder is used as the recording software (both
Brain Products GmbH, Munich, Germany). Silver/silver-chloride-
electrodes attached to nylon caps [BrainCap with 32 channels
(Easycap, Herrsching-Breitbrunn, Germany)] in accordance with
the international 10%-system are applied to the scalp. Impedances
are strictly kept below 10 kΩ. EEG Channels are referenced to FCz.
The following electroencephalographic paradigms were used
in the study.
Somatosensory evoked potentials
Human median nerve somatosensory evoked potentials (SEP)
provide the possibility of investigating thalamocortical and early
cortical processing (68). SEP of the median nerve show brief high-
frequency oscillations (~600 Hz), which underlie the primary cor-
tical low-frequency negative peak 20 ms after stimulation. Altered
latency and amplitude of SEP have been shown to be present in
schizophrenia (69).
Loudness dependence of auditory evoked potentials
The loudness dependence of auditory evoked potentials (LDAEP)
is considered to be an indicator of the brain’s serotonergic func-
tioning. Moreover, there are hints of influences of other neu-
rotransmitters than serotonin (70, 71). The LDAEP is altered
in patients with schizophrenia (72–75). Stimulus tones of five
intensities (60, 70, 80, 90, and 100 dB) were presented.
Mismatch negativity
The mismatch negativity (MMN) is supposed to reflect an auto-
matic, preattentive process for change detection (76, 77). A dys-
function in the glutamatergic receptor system is considered to play
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an important role in schizophrenia-related deficits in MMN (78,
79). In the present study, the MMN paradigm includes changes in
frequency, intensity, and duration of tones in repetitive acoustic
stimulation.
NoGo anteriorization
For the investigation of response control, i.e., the execution (Go)
and the inhibition (NoGo) of an anticipated motor response, the
continuous performance test (CPT) (55) was used. The gravity
center (centroid) of the ERP elicited during the NoGo-condition
is located more anteriorly as compared to the Go-condition in
healthy subjects and this effect has been reported to be smaller in
patients with schizophrenia (80, 81).
Near-infrared spectroscopy
Changes in frontal oxygenation parameters O2Hb and HHb are
measured with a 52-channel near-infrared spectroscopy-system,
Optical Topography® System (Hitachi ETG-4000), light sources
within this system are 18 semiconductor lasers of 695 and 830 nm
wavelength. For the positioning of the fibreoptics probes with dis-
tances of 30 mm between signal and detector are used (both Hitach
Medical Corporation, Tokyo, Japan). Data sampling rate is set as
10 samplings per second. Measurement channels cover large areas
of the prefrontal cortex, motor, and premotor regions and superior
temporal cortex.
Cognitive paradigms employed in the neurophysiological
examinations included the Verbal-Fluency Test (semantic and
phonemic) performed according to Ehlis et al. (82) and Hermann
et al. (83), and the emotional Stroop Test (84, 85).
SOCIOPHYSIOLOGY AND SOCIAL COGNITION
Motor empathy was assessed using the Resonance Test (86, 87).
In this behavioral paradigm, contagion by yawning and laughing
is rated while participants view short video sequences of yawning
and laughing faces.
Different aspects of visual emotion recognition in faces were
assessed using several items of the “University of Pennsylvania
Computerized Neuropsychological Testing Systems” (88): Penn
Facial Memory Test (89), Penn Emotion Recognition Task (90),
Penn Emotion Discrimination Task (91), and Penn Facial Emotion
Acuity Task (92).
Visual recognition of complex emotions and intentions was
assessed using the reading the mind in the eyes task (93).
Social attribution style according to the theory of Kelley and
Levine (94) was assessed including a paradigm developed by
Rössler and Lackus (95).
The ability to differentiate between self and other on the level
of visual feedback to motor actions was assessed using a source
monitoring or agency task (96, 97).
Subjective experience of empathic abilities was assessed using
the Interpersonal Reactivity Index 28-item Self-Report Ques-
tionnaire that comprises four subscales: fantasy scale, empathic
concern, perspective taking, and personal distress (98, 99).
STIGMA MEASURES
Perceived stigma was assessed using the 12-item Perceived
Devaluation-Discrimination Questionnaire (100). Three items
measured perceived legitimacy of discrimination or whether par-
ticipants felt discrimination against people with mental illness
was fair (101, 102). General self-esteem was examined using the
10-item Rosenberg Self-Esteem Scale (103). The desire for social
distance from people with mental illness was measured using a
5-item Social Distance Scale (104). We used eight items to assess
the cognitive appraisal of stigma as a stressor (105, 106), adapted
from Kaiser and colleagues (107). The perception of people with
mental illness as a distinct and coherent group in society (entita-
tivity) was measured using four items (108). Group values were
assessed by two items on whether respondents felt people with
mental illness were a good group in society. The level of identifi-
cation with the group of people with mental illness was examined
by five items (101, 109).
SAMPLE
In 28 months, 305 persons were screened. Eligible participants
(n= 273) gave informed consent to participate in the study; 52
withdrew their consent before baseline examination was com-
pleted. Therefore, 221 persons entered the study group, of whom
133 (60.2%) were male. The mean age of the sample was 20.99
(±6.0) years (range 13–35 years, median 20 years) with no sig-
nificant difference between males (21.25± 6.1 years) and females
(20.60± 5.7 years).
Among the 221 subjects, most reported COPER (70.1%),
COGDIS (53.4%), and APS (44.3%). Genetic risk plus reduced
functioning criterion (7.2%) as well as BLIPS (3.6%) were reported
noticeably less frequently. Further, 155 (70.1%) subjects showed
14 or more symptoms on the Hypomania Checklist (HCL-32) and
133 (60.2%) had a score of 12 or more on the HAMD. Also, 147
(66.5%) subjects had a score of 10 or more on the BAI.
Of the subjects, 28.1% met only one inclusion criterion, 43.8%
met two and 28.1% met all three inclusion criteria (HR, UHR,
at-risk bp). Only a small group of 3.2% (7 subjects) was included
on the basis of cognitive disturbances alone.
Among the 221 participants, 81 (36.7%) fulfilled high risk and
107 (48.4%) UHR criteria for psychosis, 155 (70%) fulfilled risk
criteria for bipolar disorder.
DISCUSSION
During the last decades, there has been a considerable increase of
Early Recognition and Intervention services. While “HR” studies
in psychosis are numerous “HR” research in bipolar disorder are
emerging. Conceptualization of early recognition of at-risk phases
of psychosis and bipolar disorder is complicated due to the mix of
heterogeneity and overlap regarding genetic and phenomenologi-
cal aspects. The ZInEP “early recognition” longitudinal study aims
to better understand the predictors of psychosis/bipolar disorder
onset and mechanisms for the development of both disorders.
Focusing on both the psychosis at-risk and the bipolar at-risk
group, we confirm an overlap between the different at-risk groups.
Recently, the European Prediction of Psychosis Study (EPOS)
group suggested a 2-step risk assessment, with UHR and cogni-
tive disturbance criteria for general risk and the prognostic scores
as a second-step tool for further risk classification. They propose
testing a multi-level model including additional neurocognitive,
neurobiological, socio-biographical, and environmental variables
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to see if this model increases predictive accuracy (8). Similarly to
EPOS and contrary to NAPLES (110) our group shows a lower
proportion of persons with a positive family history. With 221
persons included in the ZInEP “early recognition-sample” we aim
to improve individual risk assessment by developing an optimized
prediction model. Focusing in addition on the putative “at-risk
bipolar” group, we will have the opportunity to test the proposed
risk criteria for bipolar disorder.
The development of at-risk criteria for first-episode psychosis
is advanced in comparison to the developmental stage of the
at-risk criteria for first-episode mania. Currently, there is no con-
sensus on the definition of the bipolar prodrome (111). Further
investigation of subthreshold symptoms is needed to identify
potential prodromal symptoms. After completing the follow-up
period it will be possible to refine the risk criteria for true “at-risk
bipolar” individuals. Adding, e.g., imaging or neuropsychologi-
cal data could further increase their predictive power (112). The
bipolar-spectrum concept may also provide research for affective
disorders by facilitating identification of early stage bipolar disor-
der (113). The concept, as suggested by Angst et al., comprises
a continuum of severity and a continuum from depression to
mania, providing a more differentiated research model for affec-
tive disorders. This corresponds to the genetic findings as quoted
previously.
A dimensional approach with a focus on the major compo-
nents of these disorders, i.e., mania, psychosis (and depression)
could be a helpful strategy to disentangle subjects at-risk for
mania and those at-risk for psychosis. Examinations of the familial
aggregation patterns of the core components of psychosis, mania,
and major depression suggest a strong familial specificity (114).
Familial aggregation of bipolar disorder seems to be attributed to
mania (115). Family studies demonstrated the independence of
the familial transmission of mania and depression (114, 115).
Age also seems to play an important role in the distribution
pattern of the different risk states with assumed different trajecto-
ries. In our sample, we will be able to examine, if the “adolescent
risk-sample” differs significantly from the “adult risk-sample” in
the symptom distribution. The adolescent group may develop
a higher symptom load at an earlier stage, which could corre-
late with marked increases in neurobiological changes. Besides
the on-going follow-up examination, we will analyze our recent
data regarding potential correlations with data from genetic,
neuropsychology, electrophysiology, MRI, sociophysiology/social
cognition, stigma, resilience, stress coping, and environmental
factors.
Up to now in our sample risk group, affiliation and transition to
psychosis were predicted by different neuropsychological deficits,
which also had a profound effect on an individual’s level of general
functioning and satisfaction with life (116).
Addington and Heinssen point out that an improved prediction
model should also include biomarkers (117). Using refined pre-
diction models will help understand the development of psychotic
disorders. But taking into account that a subgroup, even if they do
not develop full-blown psychosis, does not necessarily experience
complete remission of symptoms or improvement in functioning
either, it is necessary to consider the possibility of being at-risk for
mental disorders other than psychosis (118).
Also, improved prediction models encourage research on early
intervention in persons with a higher risk for psychosis. Under-
standing the biological and environmental mechanisms involved
in the onset of psychosis will help to discover potentially disease-
modifying interventions. Trying to overcome problems, which
arise due to categorical diagnosis, augmentation with symptom,
time, severity, and persistence dimensions were recently suggested
(119). Their proponents state that a prevention-oriented frame-
work for evaluation of interventions can be provided by defining
discrete stages according to progression of disease.
But early detection could unintentionally entail the “mental
illness” label and may negatively affect service use. In our sam-
ple stronger self-labeling and less stigma stress predicted better
attitudes toward psychiatric medication and psychotherapy. In
addition, stigma stress, but not the level of perceived public stigma,
predicted more negative attitudes toward help-seeking (120). Per-
ceived public stigma appears to be associated with reduced well-
being among young people at-risk of psychosis (121). Well-being is
influenced moreover by changes of self-labeling and stigma stress
over time independent of baseline levels (122). A non-stigmatizing
use of (self-) labeling could reduce stigma stress and its impact on
young people at-risk for psychosis (120). This highlights the need
for specific interventions regarding stigma.
Despite the considerable evidence, which has been accumulated
on early recognition of psychosis, there is a shortage of research
findings regarding (a) the underlying biological mechanisms, (b)
valid risk criteria for bipolar disorder, and (c) the developmen-
tal trajectories. The ZInEP “early recognition”-study enables to
test the possible contributions of this multi-level-approach and
thereby to contribute to an improved prediction.
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